New research shows that blood from older animals can speed up Alzheimer’s-related changes in the brain, while young blood may ...

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...

But here’s an alarming turn in the Alzheimer’s saga: scientists have a hunch that a single cell problem, in which constant ...

A new study shows that components found in aged blood can speed up the buildup of amyloid proteins and alter behavior in an ...

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according to new research. Scientists have found that a byproduct of amyloid-beta ...

A longitudinal study of people with autosomal dominant Alzheimer’s disease (AD) shows that β-amyloid (Aβ) deposition begins well before neurodegeneration and cognitive decline. And the findings “also ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease. That’s according to a new study from Washington University School of Medicine in ...

The startup’s lead prospect stabilizes abnormal proteins in patients with amyloid “light chain” amyloidosis, an approach that ...

Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to ...